Détail du congrès:
Congrès: Congrès international de myologie 2005 (International Congress of Myology 2005; 9-13 mai 2005; Nantes, France) (9-13 mai 2005)
Commentaire :
AFM
Auteur(s) ayant un renvoi vers celui-ci :
|
Documents disponibles provenant de ce congrès (412)
trié(s) par (Date de parution décroissant(e), Date de parution décroissant(e), Système de projection du document croissant(e)) | Mettre toutes les notices dans le panier | Faire une suggestion | Ajouter un critère de recherche
Article
Congrès international de myologie 2005 (International Congress of Myology 2005; 9-13 mai 2005; Nantes, France) ; Martelly I ; Caruelle D ; Brzoska E. ; Delbe J ; Duchesnay A ; Moraczewski J ; Courty J | 2005Communication n° 101. Heparin affin regulatory peptide is a heparin binding growth factor (HARP). It belongs to a family of molecule whose biological function in myogenesis has been suspected without formal demonstration. In the present study, w[...]Article
Congrès international de myologie 2005 (International Congress of Myology 2005; 9-13 mai 2005; Nantes, France) ; Martelly I ; Caruelle D ; Brzoska E. ; Delbe J ; Duchesnay A ; Moraczewski J ; Courty J | 2005Communication n° 345. Heparin affin regulatory peptide (HARP) is a heparin binding growth factor. It belongs to a family of molecule whose biological function in myogenesis has been suspected without formal demonstration. In the present study, w[...]Article
Congrès international de myologie 2005 (International Congress of Myology 2005; 9-13 mai 2005; Nantes, France) ; Lefebvre S ; Burlet P ; Patel S ; Khoobarry K ; MacKenzie A ; Gendron N ; Munnich A | 2005Communication n° 455 Spinal muscular atrophy (SMA) is caused by mutations in the gene encoding the survival motor neuron (SMN) protein, SMN1. The SMN1 gene and its nearly identical copy SMN2 produce an identical ubiquitous SMN protein. A strong [...]Article
Congrès international de myologie 2005 (International Congress of Myology 2005; 9-13 mai 2005; Nantes, France) ; Bastin J ; Djouadi F ; Aubey F ; Schlemmer D ; Laforet P ; Wanders R ; Strauss A | 2005Communication n° 81. Inborn errors of mitochondrial fatty acid oxidation (FAO) often lead to metabolic myopathy presenting as muscle weakness, exercise intolerance and episodes of myoglobinuria. This typical phenotype is likely due to insufficie[...]Article
Congrès international de myologie 2005 (International Congress of Myology 2005; 9-13 mai 2005; Nantes, France) ; Miura P ; Jasmin B ; Thompson J ; Chakkalakal J ; Holcik M | 2005Communication n° 416. Introduction : A therapeutic strategy to treat Duchenne muscular dystrophy (DMD) is to upregulate utrophin expression in the muscles of affected patients. Our previous studies have shown that during muscle regeneration, utr[...]Article
Congrès international de myologie 2005 (International Congress of Myology 2005; 9-13 mai 2005; Nantes, France) ; Lipskaia L ; Fromes Y | 2005Communication n° 686. Proliferation of vascular smooth muscle cells (VSMC) is associated with loose of sarco/endoplasmic Ca2+-ATP-ase (SERCA2a) resulting in increase of cytosolic Ca2+ and alteration of activity of Ca2+-dependent transcription fa[...]Article
Congrès international de myologie 2005 (International Congress of Myology 2005; 9-13 mai 2005; Nantes, France) ; Doucet G ; Furling D ; Puymirat J | 2005Communication n° 413 Many viral vectors have been designed for the purpose of delivering transgenes into a variety of cells and tissues from many species. The effective delivery of the therapeutic agent in human muscle cells, and itÕs sustained [...]Article
Congrès international de myologie 2005 (International Congress of Myology 2005; 9-13 mai 2005; Nantes, France) ; Fort P ; Tadayoni R ; Yaffe D ; Nudel U ; Pannicke T ; Reichenbach A ; Sahel JA ; Paques M ; Rendon A | 2005Communication n° 524 Introduction : The dystrophin protein Dp71 is the major Duchenne muscular dystrophy (DMD) gene product in non-muscle tissues. In spite of the fact that Dp71 is required for the organization of dystrophin-associated protein c[...]Article
Congrès international de myologie 2005 (International Congress of Myology 2005; 9-13 mai 2005; Nantes, France) ; Mastroyiannopoulos N ; Feldman M ; Uney J ; Mahadevan M ; Phylactou LA | 2005Communication n° 52. Introduction : CTG trinucleotide repeat expansions in the 3' untranslated region (3' UTR) of the myotonic dystrophy protein kinase (DMPK) gene is responsible for myotonic dystrophy (DM). Mutant DMPK transcripts aggregate in [...]Article
Congrès international de myologie 2005 (International Congress of Myology 2005; 9-13 mai 2005; Nantes, France) ; Pierson CR ; Blasko J , ; Shapiro F ; Darras B ; Buj Bello A ; Mandel JL ; Beggs AH | 2005Communication n° 557. X-linked myotubular myopathy (XLMTM) is due to MTM1 mutations; the gene product is known as myotubularin. Muscle biopsy shows a high proportion of hypotrophic myofibers with centrally placed nuclei. Most of our knowledge of[...]Article
Congrès international de myologie 2005 (International Congress of Myology 2005; 9-13 mai 2005; Nantes, France) ; Molgo J ; Liberona J ; Cardenas C ; Debitus C ; Laurent D ; Jaimovich E | 2005Communication n° 567 Xestospongin B, a macrocyclic bis-1-oxaquinolizidine alkaloid extracted from the marine sponge Xestospongia exigua, was highly purified and tested for its ability to block inositol 1,4,5-trisphosphate (IP3)-induced calcium r[...]